Evidence map›Paper›PMID 31463039›Full record

ArticleBone & joint research2019

Single-dose pharmacokinetics of meropenem in porcine cancellous bone determined by microdialysis: An animal study.

Pelle Hanberg, Andrea Lund, Kjeld Søballe, Mats Bue

Open access · goldAbstract read
In one paragraph

Article in Bone & joint research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Pelle HanbergDepartment of Orthopaedic Surgery, Horsens Regional Hospital and Orthopaedic Research Unit, Aarhus University Hospital, Horsens, Denmark and Aarhus, Denmark.
Andrea LundOrthopaedic Research Unit, Aarhus University Hospital, Aarhus, Denmark.
Kjeld SøballeOrthopaedic Research Unit, Aarhus University Hospital, Aarhus, Denmark; Department of Orthopaedic Surgery, Aarhus University Hospital, Aarhus, Denmark.
Mats BueDepartment of Orthopaedic Surgery, Horsens Regional Hospital and Orthopaedic Research Unit, Aarhus University Hospital, Horsens, Denmark and Aarhus, Denmark.
Aarhus University Hospital · DKRegional Hospital Horsens · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesMeropenem may be an important drug in the treatment of open tibial fractures and chronic osteomyelitis. Therefore, the objective of this study was to describe meropenem pharmacokinetics in plasma, subcutaneous adipose tissue (SCT), and cancellous bone using microdialysis in a porcine model.

methodsSix female pigs were assigned to receive 1000 mg of meropenem intravenously over five minutes. Measurements of meropenem were obtained from plasma, SCT, and cancellous bone for eight hours thereafter. Microdialysis was applied for sampling in solid tissues. The meropenem concentrations were determined using ultra-high-performance liquid chromatography.

resultsThe penetration of meropenem into cancellous bone, expressed as the ratio of plasma to cancellous bone area under the concentration-curve from zero to the last measured value, was incomplete and delayed. The time with concentration above the minimal inhibitory concentration (T

conclusionThe main finding of this study was short T

Indexed as

BoneMeropenemMicrodialysisPenetrationPharmacokinetics

Identifiers

PMID31463039
PMCPMC6691366
OpenAlexW2962982307

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.